Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue factor and tissue factor pathway inhibitor.

G C Price1, S A Thompson, P C A Kam

  • 1Intensive Care Unit, University of New South Wales at St George Hospital, Kogarah, NSW 2217, Australia.

Anaesthesia
|April 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemispheric asymmetry in ocean change and the productivity of ecosystem sentinels.

Science (New York, N.Y.)·2021
Same author

Self-assembly of gold supraparticles with crystallographically aligned and strongly coupled nanoparticle building blocks for SERS and photothermal therapy.

Chemical science·2018
Same author

Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations.

Anaesthesia·2018
Same author

An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis.

Oncogenesis·2016
Same author

The effects of haemodilution with hydroxyethyl starch 130/0.4 solution on coagulation as assessed by thromboelastography and platelet receptor function studies in vitro.

Anaesthesia and intensive care·2015
Same author

Ictal infraslow activity in stereoelectroencephalography: Beyond the "DC shift".

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2015
Same journal

Variation in peri-operative management of GLP-1 receptor agonists among UK anaesthetists.

Anaesthesia·2026
Same journal

Management of major thoracic trauma: a narrative review.

Anaesthesia·2026
Same journal

Pulmonary artery catheters or central venous catheters for cardiac surgery: the PUMA Pilot randomised clinical trial.

Anaesthesia·2026
Same journal

Opioid-free vs. opioid-inclusive anaesthesia with or without regional anaesthesia for postoperative pain.

Anaesthesia·2026
Same journal

Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention: a reply.

Anaesthesia·2026
Same journal

Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention.

Anaesthesia·2026
See all related articles

The classical coagulation cascade model is outdated. Tissue factor initiates blood clotting in vivo, with roles beyond hemostasis in diseases like sepsis and cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • The traditional coagulation cascade model describes intrinsic and extrinsic pathways.
  • Recent data highlights tissue factor/factor-VII as the primary in vivo initiator.
  • Tissue factor pathway inhibitor discovery supports a revised coagulation theory.

Purpose of the Study:

  • To present the revised understanding of coagulation initiation and propagation.
  • To discuss the multifaceted roles of tissue factor beyond hemostasis.

Main Methods:

  • Review of molecular biology and clinical data.
  • Analysis of findings related to tissue factor pathway inhibitor.
  • Examination of evidence on blood-borne tissue factor functions.

Related Experiment Videos

Main Results:

  • Tissue factor/factor-VII interaction is the primary in vivo coagulation initiator.
  • Coagulation involves distinct initiation and propagation phases.
  • Tissue factor acts as a signaling receptor with roles in sepsis, atherosclerosis, cancer, immune function, and metastasis.

Conclusions:

  • The classical cascade hypothesis is superseded by a revised model of coagulation.
  • Tissue factor plays a critical role in initiating coagulation and has significant non-hemostatic functions.